JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

Search

Quidel Corp

Fechado

11.21 -5.88

Visão Geral

Variação de preço das ações

24h

Atual

Mín

10.83

Máximo

11.88

Indicadores-chave

By Trading Economics

Rendimento

602M

-131M

Vendas

24M

724M

Margem de lucro

-18.062

Funcionários

6,500

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+73.7% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-483M

726M

Abertura anterior

17.09

Fecho anterior

11.21

Quidel Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de abr. de 2026, 00:00 UTC

Ganhos

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24 de abr. de 2026, 00:00 UTC

Ganhos

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23 de abr. de 2026, 23:47 UTC

Conversa de Mercado

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

23 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

23 de abr. de 2026, 23:43 UTC

Conversa de Mercado

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23 de abr. de 2026, 23:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23 de abr. de 2026, 22:33 UTC

Ganhos

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23 de abr. de 2026, 22:17 UTC

Ganhos

PLS Executed Offtake Agreement With Ronbay

23 de abr. de 2026, 22:17 UTC

Ganhos

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23 de abr. de 2026, 22:16 UTC

Ganhos

PLS Commences Commissioning of Midstream Demonstration Plant

23 de abr. de 2026, 22:15 UTC

Ganhos

PLS Group Reaffirms FY26 Guidance for All Metrics

23 de abr. de 2026, 22:14 UTC

Ganhos

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23 de abr. de 2026, 22:14 UTC

Ganhos

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23 de abr. de 2026, 22:13 UTC

Ganhos

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23 de abr. de 2026, 22:12 UTC

Ganhos

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23 de abr. de 2026, 22:12 UTC

Ganhos

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23 de abr. de 2026, 22:11 UTC

Ganhos

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23 de abr. de 2026, 22:10 UTC

Ganhos

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23 de abr. de 2026, 22:09 UTC

Ganhos

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23 de abr. de 2026, 22:08 UTC

Ganhos

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23 de abr. de 2026, 22:04 UTC

Ganhos

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23 de abr. de 2026, 21:56 UTC

Conversa de Mercado
Ganhos

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23 de abr. de 2026, 21:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23 de abr. de 2026, 21:27 UTC

Ganhos

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23 de abr. de 2026, 21:25 UTC

Ganhos

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23 de abr. de 2026, 21:24 UTC

Ganhos

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23 de abr. de 2026, 21:24 UTC

Ganhos

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23 de abr. de 2026, 21:21 UTC

Ganhos

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23 de abr. de 2026, 21:21 UTC

Ganhos

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Comparação entre Pares

Variação de preço

Quidel Corp Previsão

Preço-alvo

By TipRanks

73.7% parte superior

Previsão para 12 meses

Média 20.67 USD  73.7%

Máximo 30 USD

Mínimo 15 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Quidel Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

5 ratings

1

Comprar

3

Manter

1

Vender

Informação Financeira

Custos administrativos e de venda

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

Resultado Operacional

$

Sobre Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat